Asher Bio

Asher Bio is a biotechnology company dedicated to developing precision-targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to achieve selective activation of specific immune cell types, addressing the inherent limitations of pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely target various immune mediators to a range of target immune cell types, creating best-in-class immunotherapies for cancer, autoimmune, and infectious diseases.